Systemic CD8+ T cell-mediated tumoricidal effects by intratumoral treatment of oncolytic herpes simplex virus with the agonistic monoclonal antibody for murine glucocorticoid-induced tumor necrosis factor receptor.
Oncolytic virotherapy combined with immunomodulators is a novel noninvasive strategy for cancer treatment. In this study, we examined the tumoricidal effects of oncolytic HF10, a naturally occurring mutant of herpes simplex virus type-1, combined with an agonistic DTA-1 monoclonal antibody specific...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4126744?pdf=render |
| _version_ | 1828542062668021760 |
|---|---|
| author | Mikiya Ishihara Naohiro Seo Jun Mitsui Daisuke Muraoka Maki Tanaka Junichi Mineno Hiroaki Ikeda Hiroshi Shiku |
| author_facet | Mikiya Ishihara Naohiro Seo Jun Mitsui Daisuke Muraoka Maki Tanaka Junichi Mineno Hiroaki Ikeda Hiroshi Shiku |
| author_sort | Mikiya Ishihara |
| collection | DOAJ |
| description | Oncolytic virotherapy combined with immunomodulators is a novel noninvasive strategy for cancer treatment. In this study, we examined the tumoricidal effects of oncolytic HF10, a naturally occurring mutant of herpes simplex virus type-1, combined with an agonistic DTA-1 monoclonal antibody specific for the glucocorticoid-induced tumor necrosis factor receptor. Two murine tumor models were used to evaluate the therapeutic efficacies of HF10 virotherapy combined with DTA-1. The kinetics and immunological mechanisms of DTA-1 in HF10 infection were examined using flow cytometry and immunohistochemistry. Intratumoral administration of HF10 in combination with DTA-1 at a low dose resulted in a more vigorous attenuation of growth of the untreated contralateral as well as the treated tumors than treatment with either HF10 or DTA-1 alone. An accumulation of CD8(+) T cells, including tumor- and herpes simplex virus type-1-specific populations, and a decrease in the number of CD4(+) Foxp3(+) T regulatory cells were seen in both HF10- and DTA-1-treated tumors. Studies using Fc-digested DTA-1 and Fcγ receptor knockout mice demonstrated the direct participation of DTA-1 in regulatory T cell depletion by antibody-dependent cellular cytotoxicity primarily via macrophages. These results indicated the potential therapeutic efficacy of a glucocorticoid-induced tumor necrosis factor receptor-specific monoclonal antibody in oncolytic virotherapy at local tumor sites. |
| first_indexed | 2024-12-12T01:49:36Z |
| format | Article |
| id | doaj.art-b4c2568ef7964636b69074bd269bb944 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-12T01:49:36Z |
| publishDate | 2014-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-b4c2568ef7964636b69074bd269bb9442022-12-22T00:42:31ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0198e10466910.1371/journal.pone.0104669Systemic CD8+ T cell-mediated tumoricidal effects by intratumoral treatment of oncolytic herpes simplex virus with the agonistic monoclonal antibody for murine glucocorticoid-induced tumor necrosis factor receptor.Mikiya IshiharaNaohiro SeoJun MitsuiDaisuke MuraokaMaki TanakaJunichi MinenoHiroaki IkedaHiroshi ShikuOncolytic virotherapy combined with immunomodulators is a novel noninvasive strategy for cancer treatment. In this study, we examined the tumoricidal effects of oncolytic HF10, a naturally occurring mutant of herpes simplex virus type-1, combined with an agonistic DTA-1 monoclonal antibody specific for the glucocorticoid-induced tumor necrosis factor receptor. Two murine tumor models were used to evaluate the therapeutic efficacies of HF10 virotherapy combined with DTA-1. The kinetics and immunological mechanisms of DTA-1 in HF10 infection were examined using flow cytometry and immunohistochemistry. Intratumoral administration of HF10 in combination with DTA-1 at a low dose resulted in a more vigorous attenuation of growth of the untreated contralateral as well as the treated tumors than treatment with either HF10 or DTA-1 alone. An accumulation of CD8(+) T cells, including tumor- and herpes simplex virus type-1-specific populations, and a decrease in the number of CD4(+) Foxp3(+) T regulatory cells were seen in both HF10- and DTA-1-treated tumors. Studies using Fc-digested DTA-1 and Fcγ receptor knockout mice demonstrated the direct participation of DTA-1 in regulatory T cell depletion by antibody-dependent cellular cytotoxicity primarily via macrophages. These results indicated the potential therapeutic efficacy of a glucocorticoid-induced tumor necrosis factor receptor-specific monoclonal antibody in oncolytic virotherapy at local tumor sites.http://europepmc.org/articles/PMC4126744?pdf=render |
| spellingShingle | Mikiya Ishihara Naohiro Seo Jun Mitsui Daisuke Muraoka Maki Tanaka Junichi Mineno Hiroaki Ikeda Hiroshi Shiku Systemic CD8+ T cell-mediated tumoricidal effects by intratumoral treatment of oncolytic herpes simplex virus with the agonistic monoclonal antibody for murine glucocorticoid-induced tumor necrosis factor receptor. PLoS ONE |
| title | Systemic CD8+ T cell-mediated tumoricidal effects by intratumoral treatment of oncolytic herpes simplex virus with the agonistic monoclonal antibody for murine glucocorticoid-induced tumor necrosis factor receptor. |
| title_full | Systemic CD8+ T cell-mediated tumoricidal effects by intratumoral treatment of oncolytic herpes simplex virus with the agonistic monoclonal antibody for murine glucocorticoid-induced tumor necrosis factor receptor. |
| title_fullStr | Systemic CD8+ T cell-mediated tumoricidal effects by intratumoral treatment of oncolytic herpes simplex virus with the agonistic monoclonal antibody for murine glucocorticoid-induced tumor necrosis factor receptor. |
| title_full_unstemmed | Systemic CD8+ T cell-mediated tumoricidal effects by intratumoral treatment of oncolytic herpes simplex virus with the agonistic monoclonal antibody for murine glucocorticoid-induced tumor necrosis factor receptor. |
| title_short | Systemic CD8+ T cell-mediated tumoricidal effects by intratumoral treatment of oncolytic herpes simplex virus with the agonistic monoclonal antibody for murine glucocorticoid-induced tumor necrosis factor receptor. |
| title_sort | systemic cd8 t cell mediated tumoricidal effects by intratumoral treatment of oncolytic herpes simplex virus with the agonistic monoclonal antibody for murine glucocorticoid induced tumor necrosis factor receptor |
| url | http://europepmc.org/articles/PMC4126744?pdf=render |
| work_keys_str_mv | AT mikiyaishihara systemiccd8tcellmediatedtumoricidaleffectsbyintratumoraltreatmentofoncolyticherpessimplexviruswiththeagonisticmonoclonalantibodyformurineglucocorticoidinducedtumornecrosisfactorreceptor AT naohiroseo systemiccd8tcellmediatedtumoricidaleffectsbyintratumoraltreatmentofoncolyticherpessimplexviruswiththeagonisticmonoclonalantibodyformurineglucocorticoidinducedtumornecrosisfactorreceptor AT junmitsui systemiccd8tcellmediatedtumoricidaleffectsbyintratumoraltreatmentofoncolyticherpessimplexviruswiththeagonisticmonoclonalantibodyformurineglucocorticoidinducedtumornecrosisfactorreceptor AT daisukemuraoka systemiccd8tcellmediatedtumoricidaleffectsbyintratumoraltreatmentofoncolyticherpessimplexviruswiththeagonisticmonoclonalantibodyformurineglucocorticoidinducedtumornecrosisfactorreceptor AT makitanaka systemiccd8tcellmediatedtumoricidaleffectsbyintratumoraltreatmentofoncolyticherpessimplexviruswiththeagonisticmonoclonalantibodyformurineglucocorticoidinducedtumornecrosisfactorreceptor AT junichimineno systemiccd8tcellmediatedtumoricidaleffectsbyintratumoraltreatmentofoncolyticherpessimplexviruswiththeagonisticmonoclonalantibodyformurineglucocorticoidinducedtumornecrosisfactorreceptor AT hiroakiikeda systemiccd8tcellmediatedtumoricidaleffectsbyintratumoraltreatmentofoncolyticherpessimplexviruswiththeagonisticmonoclonalantibodyformurineglucocorticoidinducedtumornecrosisfactorreceptor AT hiroshishiku systemiccd8tcellmediatedtumoricidaleffectsbyintratumoraltreatmentofoncolyticherpessimplexviruswiththeagonisticmonoclonalantibodyformurineglucocorticoidinducedtumornecrosisfactorreceptor |